CL2004001422A1 - Composicion farmaceutica que comprende un analgesico opioide y un compuesto derivado de 1-piperidinilpiperazina; su uso para la prevencion y/o tratamiento del dolor y nocicepcion, y para las nauseas y vomitos, en tratamientos de base opioide para el - Google Patents
Composicion farmaceutica que comprende un analgesico opioide y un compuesto derivado de 1-piperidinilpiperazina; su uso para la prevencion y/o tratamiento del dolor y nocicepcion, y para las nauseas y vomitos, en tratamientos de base opioide para elInfo
- Publication number
- CL2004001422A1 CL2004001422A1 CL200401422A CL2004001422A CL2004001422A1 CL 2004001422 A1 CL2004001422 A1 CL 2004001422A1 CL 200401422 A CL200401422 A CL 200401422A CL 2004001422 A CL2004001422 A CL 2004001422A CL 2004001422 A1 CL2004001422 A1 CL 2004001422A1
- Authority
- CL
- Chile
- Prior art keywords
- opioid
- vomites
- piperidinylpiperazine
- nauseas
- nociception
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title 2
- ZGABDPXDUGYGQE-UHFFFAOYSA-N 1-piperidin-1-ylpiperazine Chemical compound C1CCCCN1N1CCNCC1 ZGABDPXDUGYGQE-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000014 opioid analgesic Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 230000020341 sensory perception of pain Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP0306118 | 2003-06-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2004001422A1 true CL2004001422A1 (es) | 2005-05-27 |
Family
ID=33547554
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL200401422A CL2004001422A1 (es) | 2003-06-10 | 2004-06-08 | Composicion farmaceutica que comprende un analgesico opioide y un compuesto derivado de 1-piperidinilpiperazina; su uso para la prevencion y/o tratamiento del dolor y nocicepcion, y para las nauseas y vomitos, en tratamientos de base opioide para el |
Country Status (9)
Country | Link |
---|---|
US (1) | US20080070924A1 (es) |
AR (1) | AR044491A1 (es) |
AT (1) | ATE395062T1 (es) |
CL (1) | CL2004001422A1 (es) |
DE (1) | DE602004013772D1 (es) |
ES (1) | ES2307025T3 (es) |
MY (1) | MY137858A (es) |
TW (1) | TW200510371A (es) |
WO (1) | WO2004110451A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1734966B1 (en) | 2004-04-13 | 2013-07-31 | Incyte Corporation | Piperazinylpiperidine derivatives as chemokine receptor antagonists |
AR055831A1 (es) | 2004-12-30 | 2007-09-12 | Janssen Pharmaceutica Nv | Pepirazinilureas y piperidinilureas como moduladores de hidrolasa de amida de acidos grasos |
US8604200B2 (en) | 2005-03-08 | 2013-12-10 | Janssen Pharmaceutica N.V. | Diaza-spiro-{4,4}-nonane derivatives as neurokinin (NK1) antagonists |
WO2010081851A1 (en) | 2009-01-14 | 2010-07-22 | Genoscience Pharma | Piperidin-4-ylpiperazine compounds for the treatment of hcv infection |
WO2010124082A1 (en) * | 2009-04-22 | 2010-10-28 | Janssen Pharmaceutica Nv | Azetidinyl diamides as monoacylglycerol lipase inhibitors |
WO2011037771A1 (en) * | 2009-09-23 | 2011-03-31 | Merck Sharp & Dohme Corp. | Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism |
UA108233C2 (uk) | 2010-05-03 | 2015-04-10 | Модулятори активності гідролази амідів жирних кислот | |
PT3732994T (pt) | 2013-02-08 | 2022-12-02 | Gen Mills Inc | Produtos alimentares com reduzido teor de sódio |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2287404A (en) * | 1994-03-15 | 1995-09-20 | Pfizer | Antiinflammatory and analgesic compositions |
GB9426102D0 (en) * | 1994-12-23 | 1995-02-22 | Merck Sharp & Dohme | Pharmacuetical compositions |
NZ321575A (en) * | 1995-10-30 | 1999-05-28 | Janssen Pharmaceutica Nv | 1-(1,2-disubstituted piperidinyl)-4- substituted piperazine derivatives |
GB9723544D0 (en) * | 1997-11-07 | 1998-01-07 | Merck Sharp & Dohme | Therapeutic agents |
GB9904786D0 (en) * | 1999-03-02 | 1999-04-28 | Merck Sharp & Dohme | Therapeutic agents |
US6759520B1 (en) * | 1999-10-28 | 2004-07-06 | The New England Medical Center Hospitals, Inc. | Chimeric analgesic peptides |
GB0025354D0 (en) * | 2000-10-17 | 2000-11-29 | Glaxo Group Ltd | Chemical compounds |
GB0203022D0 (en) * | 2002-02-08 | 2002-03-27 | Glaxo Group Ltd | Chemical compounds |
-
2004
- 2004-06-07 DE DE602004013772T patent/DE602004013772D1/de not_active Expired - Lifetime
- 2004-06-07 ES ES04741745T patent/ES2307025T3/es not_active Expired - Lifetime
- 2004-06-07 AT AT04741745T patent/ATE395062T1/de not_active IP Right Cessation
- 2004-06-07 WO PCT/EP2004/051050 patent/WO2004110451A1/en active IP Right Grant
- 2004-06-07 US US10/560,482 patent/US20080070924A1/en not_active Abandoned
- 2004-06-08 MY MYPI20042194A patent/MY137858A/en unknown
- 2004-06-08 CL CL200401422A patent/CL2004001422A1/es unknown
- 2004-06-09 AR ARP040101993A patent/AR044491A1/es not_active Application Discontinuation
- 2004-06-09 TW TW093116489A patent/TW200510371A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
ATE395062T1 (de) | 2008-05-15 |
AR044491A1 (es) | 2005-09-14 |
TW200510371A (en) | 2005-03-16 |
DE602004013772D1 (de) | 2008-06-26 |
ES2307025T3 (es) | 2008-11-16 |
US20080070924A1 (en) | 2008-03-20 |
WO2004110451A1 (en) | 2004-12-23 |
MY137858A (en) | 2009-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP055701A (es) | Nuevos derivados de pirimidinamida y el uso de los mismos | |
AR028296A1 (es) | Metodos sinergisticos y composiciones para el tratamiento del cancer | |
CL2003002353A1 (es) | Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic | |
CL2009001279A1 (es) | Compuestos derivados de nociceptina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor (sol. divisional 2103-03). | |
CY2014028I1 (el) | Ενωσεις, φαρμακοτεχνικες μορφες και μεθοδοι θεραπειας ή αποτροπhς ροδοχρωμης ακμης | |
PT1313489E (pt) | Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet | |
HN2002000275A (es) | Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados | |
BR0313747A (pt) | Inibidores de transcriptase reversa de não-nucleosìdeo | |
CL2004000643A1 (es) | Composicion farmaceutica que comprende un agonista de 5-ht 1b/1d y un inhibidor selectivo de ciclooxigenasa-2, util en el tratamiento de la migrana. | |
NO20055136D0 (no) | Farmasoytisk sammensetning som innbeffatter et immunosuppressivt stoff for bruk ved behandling av hudsykdommer | |
BRPI0410049A (pt) | composto ou um sal ou estereoisÈmero farmaceuticamente aceitável do mesmo, uso de um composto, composição farmacêutica, e, kit farmacêutico | |
EA200702282A1 (ru) | Комбинация феррохина и производного артемизинина для лечения малярии | |
WO2007056142A3 (en) | Methods of preventing the serotonin syndrome and compositions for use therefor | |
ECSP045171A (es) | Régimen de dosificación y composición farmacéutica para anticoncepción de emergencia | |
WO2005107467A3 (en) | Compositions including opioids and methods of their use in treating pain | |
CL2008002082A1 (es) | Compuestos derivados de 6-fenil-1h-imidazo[4,5-c]piridina-4-carbonitrilo, inhibidores de catepsina s y catepsina k; composicion farmaceutica; y uso en el tratamiento de osteoporosis, aterosclerosis, inflamacion, entre otras enfermedades. | |
CL2004001365A1 (es) | Compuestos derivados de 3-fluoropiperidina; composicion farmaceutica que lo comprende; y uso del compuesto para tratar o prevenir el dolor o la enfermedad de parkinson. | |
CL2004001012A1 (es) | Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topica | |
CL2004001422A1 (es) | Composicion farmaceutica que comprende un analgesico opioide y un compuesto derivado de 1-piperidinilpiperazina; su uso para la prevencion y/o tratamiento del dolor y nocicepcion, y para las nauseas y vomitos, en tratamientos de base opioide para el | |
NO20035602D0 (no) | Sammensetning som omfatter en PDE-4-inhibitor og H1- reseptorantagonist, samt anvendelse derav til fremstilling av et medikament forbehandling av åndedrettsykdommer | |
CL2004001421A1 (es) | Composicion farmaceutica que comprende un compuesto derivado de 1,4-dipiperidin-4-il-piperazina; y su uso para la prevencion y/o tratamiento del dolor. | |
CL2007002315A1 (es) | Compuestos derivados de piridina;composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en enfermedades o trastornos que comprenden el dolor y/o sindrome del intestino irritable. | |
NO20051261L (no) | Morfin-6-glukuronidsalt | |
CL2008000965A1 (es) | Composicion farmaceutica que comprende un agente antiinflamatorio no esteroideo y un analgesico opiaceo, y su uso para el tratamiento del dolor. | |
CL2004002030A1 (es) | Uso de interferon y ribavirina porque sirve para preparar un medicamento para tratar infecciones virales; composicion farmaceutica que comprende interferon, ribavirina y opcionalmente antioxidante; kit y su uso para preparar un medicamento para trata |